Document detailing gene therapy and care for children with epidermolysis bullosa, also known as "butterfly children."
Image of a document titled "Gene Therapy for 'Butterfly Children'" discussing epidermolysis bullosa, its effects, and treatment options.
JPG
1620×1251
293.5 KB
Free · Personal Use
Quality Assured by Worksheets Library Team
Reviewed for educational accuracy and age-appropriateness
ID: #594909
⭐
Show Answer Key & Explanations
Step-by-step solution for: SOLUTION: Gene therapy for the butterfly children - Studypool
▼
Show Answer Key & Explanations
Step-by-step solution for: SOLUTION: Gene therapy for the butterfly children - Studypool
The image you've uploaded contains a worksheet titled "Gene Therapy for 'Butterfly Children'" that discusses epidermolysis bullosa (EB), specifically the severe form known as Recessive Dystrophic Epidermolysis Bullosa (RDEB). The text explains the condition, its symptoms, current treatments, and emerging gene therapies.
Below is a detailed explanation of the content, including answers to the four questions on the worksheet, along with clarifications and scientific context.
---
- Epidermolysis bullosa (EB) is a rare genetic disorder characterized by extremely fragile skin that blisters or tears easily from minor friction or trauma.
- The name "butterfly children" comes from the fragility of their skin, likened to butterfly wings.
- RDEB is one of the most severe forms, caused by mutations in the COL7A1 gene, which codes for type VII collagen—a protein essential for anchoring the skin layers together.
---
#### 1. What part of the body is affected by epidermolysis bullosa?
> Answer: The skin.
- While primarily affecting the skin, RDEB can also impact mucous membranes such as those in the mouth, esophagus, eyes, and genitals.
- The disease causes blistering, peeling, and scarring across the body due to mechanical stress.
---
#### 2. How is the disease currently treated?
> Answer: Intensive care is given to patients by giving them daily full body bandages as well as the use of antibiotics and antiseptics. Surgical procedures and other treatments are given to patients who experience complications such as blisters and deformities.
- Daily wound care: Patients require full-body bandaging using special low-adhesion polymers to prevent further damage when changing dressings.
- Antibiotics and antiseptics: Used to prevent infections in open wounds.
- Bathing: Often involves bleach or vinegar solutions to kill bacteria.
- Surgical interventions: May be needed for:
- Contractures (tightening of joints)
- Finger fusion ("mitten" deformities)
- Esophageal strictures (narrowing of the food pipe)
- Skin cancer removal (due to high risk)
> ⚠️ Note: There is no cure yet; treatment is symptomatic and supportive.
---
#### 3. What is a "contracture"?
> Answer: It is when rigid joints and deformities become more evident because the damaged skin has shrunk, and the muscles and tendons beneath the skin have tightened.
- Contractures occur due to chronic scarring and skin shrinkage.
- As scars tighten over time, they pull on underlying tissues (muscles, tendons), restricting movement.
- This commonly affects hands, feet, and joints, leading to permanent deformities like fused fingers ("mitten hands").
---
#### 4. Describe the role of Type VII collagen in skin?
> Answer: They connect the thin layer of skin (epidermis) to the deeper layer (dermis).
- Type VII collagen is a key structural protein that forms anchoring fibrils.
- These fibrils anchor the epidermis to the dermis, preventing separation under mechanical stress.
- In RDEB, mutations in the COL7A1 gene result in deficient or dysfunctional type VII collagen, so the skin layers separate easily, causing blistering.
> 💡 In healthy skin: Anchoring fibrils made of type VII collagen act like "staples" holding the skin layers together.
---
- Fibrocell, a biotech company, is developing gene therapy targeting fibroblasts (skin cells).
- Their method involves gene-boosted fibroblasts that produce functional type VII collagen.
- In trials:
- After 12 weeks, four out of five wounds showed ≥70% healing.
- Type VII collagen was produced, but anchoring fibrils were not yet observed — indicating early progress but not full restoration.
> 🔮 Future potential: Gene therapy could lead to true healing instead of just managing symptoms.
---
| Aspect | Details |
|------|--------|
| Condition | Recessive Dystrophic Epidermolysis Bullosa (RDEB) |
| Cause | Mutation in COL7A1 gene → lack of functional type VII collagen |
| Symptoms | Blistering, scarring, contractures, infection risk |
| Current Treatment | Bandages, antibiotics, surgery, pain management |
| Gene Therapy Goal | Restore production of type VII collagen via modified fibroblasts |
| Hope | Long-term healing and improved quality of life |
---
This worksheet highlights both the devastating impact of RDEB and the promising future of gene therapy. While current care focuses on symptom management, new approaches aim to correct the root genetic cause, offering hope for a cure.
Let me know if you'd like help creating a presentation, study guide, or diagram based on this!
Below is a detailed explanation of the content, including answers to the four questions on the worksheet, along with clarifications and scientific context.
---
🔍 Overview of Epidermolysis Bullosa (EB)
- Epidermolysis bullosa (EB) is a rare genetic disorder characterized by extremely fragile skin that blisters or tears easily from minor friction or trauma.
- The name "butterfly children" comes from the fragility of their skin, likened to butterfly wings.
- RDEB is one of the most severe forms, caused by mutations in the COL7A1 gene, which codes for type VII collagen—a protein essential for anchoring the skin layers together.
---
✔ Answering the Questions
#### 1. What part of the body is affected by epidermolysis bullosa?
> Answer: The skin.
- While primarily affecting the skin, RDEB can also impact mucous membranes such as those in the mouth, esophagus, eyes, and genitals.
- The disease causes blistering, peeling, and scarring across the body due to mechanical stress.
---
#### 2. How is the disease currently treated?
> Answer: Intensive care is given to patients by giving them daily full body bandages as well as the use of antibiotics and antiseptics. Surgical procedures and other treatments are given to patients who experience complications such as blisters and deformities.
- Daily wound care: Patients require full-body bandaging using special low-adhesion polymers to prevent further damage when changing dressings.
- Antibiotics and antiseptics: Used to prevent infections in open wounds.
- Bathing: Often involves bleach or vinegar solutions to kill bacteria.
- Surgical interventions: May be needed for:
- Contractures (tightening of joints)
- Finger fusion ("mitten" deformities)
- Esophageal strictures (narrowing of the food pipe)
- Skin cancer removal (due to high risk)
> ⚠️ Note: There is no cure yet; treatment is symptomatic and supportive.
---
#### 3. What is a "contracture"?
> Answer: It is when rigid joints and deformities become more evident because the damaged skin has shrunk, and the muscles and tendons beneath the skin have tightened.
- Contractures occur due to chronic scarring and skin shrinkage.
- As scars tighten over time, they pull on underlying tissues (muscles, tendons), restricting movement.
- This commonly affects hands, feet, and joints, leading to permanent deformities like fused fingers ("mitten hands").
---
#### 4. Describe the role of Type VII collagen in skin?
> Answer: They connect the thin layer of skin (epidermis) to the deeper layer (dermis).
- Type VII collagen is a key structural protein that forms anchoring fibrils.
- These fibrils anchor the epidermis to the dermis, preventing separation under mechanical stress.
- In RDEB, mutations in the COL7A1 gene result in deficient or dysfunctional type VII collagen, so the skin layers separate easily, causing blistering.
> 💡 In healthy skin: Anchoring fibrils made of type VII collagen act like "staples" holding the skin layers together.
---
🧬 Emerging Gene Therapy – Fibrocell’s Approach
- Fibrocell, a biotech company, is developing gene therapy targeting fibroblasts (skin cells).
- Their method involves gene-boosted fibroblasts that produce functional type VII collagen.
- In trials:
- After 12 weeks, four out of five wounds showed ≥70% healing.
- Type VII collagen was produced, but anchoring fibrils were not yet observed — indicating early progress but not full restoration.
> 🔮 Future potential: Gene therapy could lead to true healing instead of just managing symptoms.
---
🌟 Summary
| Aspect | Details |
|------|--------|
| Condition | Recessive Dystrophic Epidermolysis Bullosa (RDEB) |
| Cause | Mutation in COL7A1 gene → lack of functional type VII collagen |
| Symptoms | Blistering, scarring, contractures, infection risk |
| Current Treatment | Bandages, antibiotics, surgery, pain management |
| Gene Therapy Goal | Restore production of type VII collagen via modified fibroblasts |
| Hope | Long-term healing and improved quality of life |
---
📝 Final Thoughts
This worksheet highlights both the devastating impact of RDEB and the promising future of gene therapy. While current care focuses on symptom management, new approaches aim to correct the root genetic cause, offering hope for a cure.
Let me know if you'd like help creating a presentation, study guide, or diagram based on this!
Parent Tip: Review the logic above to help your child master the concept of gene therapy worksheet answers.
